Scientists have developed a bioengineered chewing gum that significantly reduces the presence of HPV and cancer-associated bacteria in oral samples, offering hope for new treatment and prevention strategies for head and neck cancer patients.
- The gum reduces HPV by 93% in oral samples.
- Two cancer-linked bacteria were nearly eradicated using the gum.
- It preserves beneficial oral microbes unlike traditional radiation therapy.
What happened
Researchers at the University of Pennsylvania developed a chewing gum that contains natural antiviral proteins from lablab beans and an antimicrobial peptide called protegrin. Laboratory testing showed the gum reduced HPV levels by 93 percent in saliva samples from patients with head and neck squamous cell carcinoma (HNSCC), a cancer often associated with HPV infection.
In addition to lowering HPV, the gum formulation brought two harmful bacteria linked to poorer cancer outcomes—Porphyromonas gingivalis and Fusobacterium nucleatum—down to nearly zero. Importantly, this treatment did not upset the balance of beneficial bacteria in the mouth, distinguishing it from some conventional therapies.
Why it feels good
Head and neck cancers have been challenging to treat effectively, with standard therapies like radiation often wiping out helpful microbes and creating an environment favoring harmful yeast. The gum's ability to target cancer-associated microbes without collateral damage presents a gentler, complementary approach that could improve patient quality of life.
Moreover, the research addresses a global health concern as HPV-related oropharyngeal cancers are rising worldwide. By reducing HPV levels and harmful bacteria simultaneously, this innovative gum offers potential to support treatment success and even serve as a preventive measure against transmission.
What to enjoy or watch next
The promising laboratory findings pave the way for clinical trials to assess the gum’s effectiveness and safety in patients. These trials will determine if this bioengineered gum can be integrated as an adjunct therapy alongside existing cancer treatments or used in preventive settings to reduce HPV infections.
As research progresses, those interested in cancer innovation and oral health might follow developments in antimicrobial therapies and bioengineered products that protect beneficial microbiomes while targeting disease agents. This gum could be a model for future multifunctional health aids.